COMMUNIQUÉS West-GlobeNewswire

Orion Group Interim Report January-March 2018
24/04/2018
ORION CORPORATION INTERIM REPORT JANUARY-MARCH 2018 24 APRIL 2018 at 12:00 EEST Orion Group Interim Report January-March 2018 Orion's net sales for continuing operations in January-March 2018 totalled EUR 247 million ( [...]
ViaDerma, Inc. Enters into a $250,000 Initial Sales Agreement with Vage Nigeria Ltd.
24/04/2018
LOS ANGELES, April 24, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to announce it has entered into a $250,000 initial sales agreement with Vage Nigeria Ltd. (“Vage”), a brand support [...]
Galapagos reports initiation of FALCON clinical trial in cystic fibrosis
24/04/2018
Our first triple combination investigational therapy for CF patients combination of '2451+'2222+'2737 multiple centers in Europe topline results expected Q3 2018 Mechelen, Belgium; 24 April 2018; 08.45 AM CET - [...]
Shire plc : Rule 2.9 Announcement
24/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 April 2018 [...]
Lysogene Signs Partnership Agreement with Dr. Hervé Moine, Researcher at the IGBMC(1) and the SATT(2) Conectus Alsace, in the Fragile X Syndrome
24/04/2018
Development of a gene therapy product for the treatment of patients with Fragile X syndrome Implementation of the project through a unique partnership First results anticipated in 2019 CAMBRIDGE, Mass. and PARIS, April [...]
Interim Report January-March 2018
24/04/2018
Summary Q1 IN BRIEF The study design for PledOx ® Phase III program has been approved by the UK Medicines Agency MHRA and accepted by the US FDA and the Central Ethics Committee of the United States PledOx ® shows [...]
Notice of annual shareholders’ meeting in Saniona AB
24/04/2018
PRESS RELEASE April 24, 2018 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders in Saniona [...]
Notification from Oasmia Pharmaceutical AB
24/04/2018
Uppsala, Sweden, April 24, 2018 – Oasmia Pharmaceutical AB hereby issues a notification regarding the issuance of the agenda for EMA’s CHMP meeting April 23 – 26. Instead of the announced oral explanation, Oasmia will [...]
Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1
24/04/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1 Paris - 24 th April 2018 -- Elias Zerhouni, M.D., Head of [...]
Départ à la retraite du Président Monde de la R&D de Sanofi, Elias Zerhouni ; L'entreprise nomme John Reed pour lui succéder à compter du 1er juillet
24/04/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Départ à la retraite du Président Monde de la R&D de Sanofi, Elias Zerhouni ; L'entreprise nomme John Reed pour lui succéder à compter du 1 er [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
24/04/2018
REGULATED INFORMATION GHENT, Belgium, 24 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May
24/04/2018
Oslo, Norway, 24 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its first quarter 2018 results on Thursday, 3 May [...]
MDxHealth Provides First Quarter 2018
24/04/2018
NEWS RELEASE REGULATED INFORMATION INTERIM TRADING UPDATE MDxHealth Provides First Quarter 2018 Business Update IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, April 24, 2018 - MDxHealth SA ("MDxHealth, or the "Company [...]
MDxHealth publie ses résultats du premier trimestre 2018
24/04/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS REGLEMENTÉES RAPPORT D'ACTIVITÉS TEMPORAIRE MDxHealth publie ses résultats du premier trimestre 2018 IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CEST, mardi 24 avril 2018 - MDxHealth SA [...]
argenx to present complete data from the Phase 2 proof-of-concept trial of efgartigimod (ARGX-113) in generalized myasthenia gravis at American Academy of Neurology (AAN) Annual Meeting
24/04/2018
Eight-week follow-up data show separation of clinical efficacy scores between treatment group and placebo group through the duration of study Total and pathogenic IgG reduction correlates with disease score improvements [...]
Axiom Real-Time Metrics Exhibiting Fusion eClinical Suite at Clinical Operations in Oncology Trials West
24/04/2018
TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at Clinical Operations in Oncology Trials West on April 24 th and 25 th in [...]
Immuron CEO to Present at RedChip Global Online Growth Conference
24/04/2018
MELBOURNE, Australia, April 23, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), Australian microbiome biopharmaceutical company focused on developing and commercialising orally delivered targeted [...]
Apellis Pharmaceuticals Announces Closing of Offering of Common Stock
24/04/2018
CRESTWOOD, Ky. and WALTHAM, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds [...]
Epizyme Provides Update Regarding Tazemetostat Clinical Program
23/04/2018
CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage company developing novel epigenetic therapies, today announced that U.S.-based enrollment of new patients into [...]

Pages